Alembic Pharmaceuticals Limited (APLLTD)
ISIN: INE901L01018 Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
599.75
11.6(1.97%)

Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations. The company also provides branded and generic formulations in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, and anti-diabetic. In addition, it exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.

Pricing Updates

TODAY'S HIGH

600.7

TODAY'S LOW

588.5

52 WEEK HIGH

848.55

52 WEEK LOW

540

Major Holders

% of Shares Held by
All Insider

70.32%

% of Shares Held by
Institutions

15.26%

% of Float Held by
Institutions

51.41%

Number of Institutions
Holding Shares

44

Company Overview

MARKET CAP

11788.86 Cr.

ETERPRISE VALUE

12266.23 Cr.

NO. OF SHARES

19.65 Cr.

BOOK VALUE

260.313

DIV. YIELD

10%

DEBT

770.63 Cr.

GROSS PROFIT

3807.58 Cr.

CASH

72.22 Cr.

REVENUE

5424.59 Cr.

REVENUE/SHARE

275.912

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments0-186.10 Cr.-186.10 Cr.-14.36 Cr.
Change To Liabilities045.27 Cr.-21.11 Cr.-50.31 Cr.
Total cashflows from Investing Activities0-838.81 Cr.-731.63 Cr.-755.60 Cr.
Net Borrowings0-1258.47 Cr.591.90 Cr.220.66 Cr.
Total Cash from Financing Activities0-597.43 Cr.154.85 Cr.59.04 Cr.
Other Liabilities0-18.04 Cr.6.80 Cr.359.01 Cr.
Total Assets0734.08 Cr.734.08 Cr.734.08 Cr.
Net Income01178.11 Cr.828.82 Cr.584.37 Cr.
Change in Cash026.22 Cr.-127.23 Cr.115.33 Cr.
Effect of Exchange Rate0-93 Lakhs41 Lakhs-7 Lakhs
Total Cash from Operating Activities01463.38 Cr.449.13 Cr.811.96 Cr.
Depreciation0183.47 Cr.156.89 Cr.114.81 Cr.
Other Cashflows from Investing Activities06.53 Cr.2.66 Cr.21.85 Cr.
Dividends Paid00-235.64 Cr.-75.41 Cr.
Change to Inventory0-298.62 Cr.-220.27 Cr.-233.33 Cr.
Change to Account Receivables0510.93 Cr.-358.26 Cr.36.19 Cr.
Other Cashflows from Financing Activities0-73.04 Cr.-144.85 Cr.-86.21 Cr.
Change to Net Income0-137.74 Cr.56.26 Cr.1.22 Cr.
Capital Expenditures0-659.51 Cr.-734.89 Cr.-653.93 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax01399.82 Cr.999.88 Cr.740.04 Cr.
Minority Interest0-60.64 Cr.-28.96 Cr.-79 Lakhs
Net Income01296.82 Cr.1111.41 Cr.741.32 Cr.
Selling General Administrative01053.03 Cr.908.96 Cr.764.02 Cr.
Gross Profit04052.91 Cr.3515.31 Cr.2903.68 Cr.
Ebit01296.82 Cr.1111.41 Cr.741.32 Cr.
Operating Income01296.82 Cr.1111.41 Cr.741.32 Cr.
Other Operating Expenses01519.64 Cr.1337.80 Cr.1270.28 Cr.
Interest Expense0-16.02 Cr.-27.16 Cr.-18.41 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense0253.32 Cr.199.18 Cr.156.75 Cr.
Total Revenue05393.12 Cr.4605.75 Cr.3934.68 Cr.
Total Operating Expenses04096.30 Cr.3494.34 Cr.3193.36 Cr.
Cost of Revenue01340.21 Cr.1090.44 Cr.1031 Cr.
Total Other Income Expense Net0103 Cr.-111.53 Cr.-1.28 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.01146.50 Cr.800.70 Cr.583.29 Cr.
Net Income Applicable to Common Shares01178.11 Cr.828.82 Cr.584.37 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets0322.94 Cr.299.02 Cr.266.26 Cr.
Capital Surplus0748.39 Cr.00
Total Liabilities01642.01 Cr.2798.60 Cr.2059.76 Cr.
Stock Holder Equity05127.61 Cr.3219.41 Cr.2718.82 Cr.
Minority Interest0-60.64 Cr.-28.96 Cr.-79 Lakhs
Other Liabilities0116.72 Cr.128.64 Cr.108.90 Cr.
Total Assets06708.98 Cr.5989.05 Cr.4777.79 Cr.
Common Stock039.31 Cr.37.70 Cr.37.70 Cr.
Retained Earnings04194.11 Cr.3074.95 Cr.2623.36 Cr.
Other Liabilities089.74 Cr.86.71 Cr.70.80 Cr.
Good Will0003.61 Cr.
Treasury Stock0145.80 Cr.106.76 Cr.57.76 Cr.
Other Assets0110.81 Cr.110.66 Cr.61.59 Cr.
Cash098.06 Cr.71.84 Cr.199.07 Cr.
Current Liabilities01280.84 Cr.1751.60 Cr.1489.66 Cr.
Long Term Asset Charges0000
Short Long Term Debt0299.88 Cr.0200 Cr.
Other Stockholder Equity0145.80 Cr.106.76 Cr.57.76 Cr.
Property Plant Equipment03648.02 Cr.3099 Cr.2439.81 Cr.
Total Cur. Assets02577.90 Cr.2462.75 Cr.1957.76 Cr.
Long Term Investments049.31 Cr.17.62 Cr.48.76 Cr.
Net Tangible Assets04804.67 Cr.2920.39 Cr.2448.95 Cr.
Short Term Investments0186.97 Cr.00
Net Receivables0365.18 Cr.895.73 Cr.488.92 Cr.
Long Term Debt0199.89 Cr.886.99 Cr.499.30 Cr.
Inventory01486.15 Cr.1187.53 Cr.967.26 Cr.
Accounts Payable0668.77 Cr.625.93 Cr.644.34 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account